These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23824051)

  • 1. Balancing access and innovation: India's Supreme Court rules on imatinib.
    Rajkumar R; Kesselheim AS
    JAMA; 2013 Jul; 310(3):263-4. PubMed ID: 23824051
    [No Abstract]   [Full Text] [Related]  

  • 2. Novartis challenges India's drug patent laws in Supreme Court.
    Billingsley M
    BMJ; 2012 Feb; 344():e1279. PubMed ID: 22354594
    [No Abstract]   [Full Text] [Related]  

  • 3. Patent dispute: Delhi High Court gives a boost to access to affordable medicines.
    Menghaney L
    Indian J Med Ethics; 2010; 7(2):97-100. PubMed ID: 20432882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intellectual property. Challenges to India's pharmaceutical patent laws.
    Sampat BN; Shadlen KC; Amin TM
    Science; 2012 Jul; 337(6093):414-5. PubMed ID: 22767892
    [No Abstract]   [Full Text] [Related]  

  • 5. Patients not patents: Drug research and development as a public enterprise.
    Gøtzsche PC
    Eur J Clin Invest; 2018 Feb; 48(2):. PubMed ID: 29243246
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of India's new patents law 2005: a physician's perspective.
    Lele RD
    J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073
    [No Abstract]   [Full Text] [Related]  

  • 7. Supreme Court of India rejects Novartis’ cancer drug patent.
    Heseltine P
    Pharm Pat Anal; 2013 May; 2(3):299-300. PubMed ID: 24237056
    [No Abstract]   [Full Text] [Related]  

  • 8. Will the Modi government succumb to US and industry pressure to modify its pro-access pharmaceutical patent policy?
    Baker BK
    Expert Opin Ther Pat; 2015 Jun; 25(6):625-8. PubMed ID: 25704359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of TRIPS on innovation and exports: a case study of the pharmaceutical industry in India.
    Malhotra P
    Indian J Med Ethics; 2008; 5(2):61-5. PubMed ID: 18624153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "To patent or not to patent? the case of Novartis' cancer drug Glivec in India".
    Gabble R; Kohler JC
    Global Health; 2014 Jan; 10():3. PubMed ID: 24393270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. India's patent ecosystem - encouraging strong patents or discouraging innovation?
    Harrison C
    Nat Rev Drug Discov; 2013 Oct; 12(10):732-3. PubMed ID: 24080690
    [No Abstract]   [Full Text] [Related]  

  • 12. Discussions in Geneva, demonstrations in Delhi: why incentives for drug innovation need reviewing.
    Ford N; 't Hoen E; von Schoen-Angerer T
    Drug Discov Today; 2007 May; 12(9-10):349-51. PubMed ID: 17467570
    [No Abstract]   [Full Text] [Related]  

  • 13. India's rejection of Novartis's patent is but a small step in the right direction.
    Bhaumik S
    BMJ; 2013 Apr; 346():f2412. PubMed ID: 23596223
    [No Abstract]   [Full Text] [Related]  

  • 14. Indian biogenerics industry emerges.
    Jayaraman KS
    Nat Biotechnol; 2003 Oct; 21(10):1115-6. PubMed ID: 14520378
    [No Abstract]   [Full Text] [Related]  

  • 15. Access to medicine and the dangers of patent linkage: lessons from Bayer Corp v. Union of India.
    Tsui M
    J Law Med; 2011 Mar; 18(3):577-88. PubMed ID: 21528741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Big nation, nano dream - the prospects of India's nanotech revolution.
    Agoramoorthy G; Chakraborty C; Hsu MJ
    Drug Discov Today; 2010 Jul; 15(13-14):495-8. PubMed ID: 20363360
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug industry in India is threatened by free trade agreement].
    Jeppsson A
    Lakartidningen; 2009 Oct 7-13; 106(41):2589. PubMed ID: 19927922
    [No Abstract]   [Full Text] [Related]  

  • 18. [The Glivec® case: the first example of a global debate on the drug patent system].
    Moital I; Bosch F; Farré M; Maddaleno M; Baños JE
    Gac Sanit; 2014; 28(6):470-4. PubMed ID: 25110309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 20. [COMPARISON OF 2 BILLS ON PHARMACEUTICAL PATENTING IN ITALY, THE EUROPEAN PATENT BILL AND THE GERMAN, ENGLISH AND UNITED STATES LAWS ON PATENTS OF INVENTIONS].
    BELLENGHI M
    Farmaco Prat; 1964 May; 19():240-51. PubMed ID: 14167551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.